D-0136-2020 Class II Terminated
FDA drug recall D-0136-2020 was initiated by Pfizer Inc. on Oct 2, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Bag has the potential to leak. The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 17832 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 16, 2019
- Initiation Date
- Oct 2, 2019
- Termination Date
- Dec 1, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17832 bags
Product description
10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13
Reason for recall
Lack of Assurance of Sterility: Bag has the potential to leak.
Distribution pattern
Nationwide in the United States and Puerto Rico
Code information
Lot #: 87-095-JT Exp. 1MAR2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0136-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.